Class action lawsuits
Sarepta Therapeutics Faces Class Action Lawsuit Over ELEVIDYS Gene Therapy
Shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) who suffered losses due to alleged securities fraud have a chance to seek recovery. A class action lawsuit was filed against the company, alleging that it made false statements and concealed the safety risks associated with its ELEVIDYS gene therapy for Duchenne. The